Walleye Trading LLC - CLOVIS ONCOLOGY INC ownership

CLOVIS ONCOLOGY INC's ticker is CLVS and the CUSIP is 189464100. A total of 119 filers reported holding CLOVIS ONCOLOGY INC in Q2 2022. The put-call ratio across all filers is 0.93 and the average weighting 0.0%.

Quarter-by-quarter ownership
Walleye Trading LLC ownership history of CLOVIS ONCOLOGY INC
ValueSharesWeighting
Q1 2022$31,000
-75.4%
15,000
-67.7%
0.00%
Q4 2021$126,000
-45.2%
46,431
-10.1%
0.00%
Q3 2021$230,000
+91.7%
51,619
+148.2%
0.00%
Q2 2021$120,000
-60.9%
20,800
-52.5%
0.00%
-100.0%
Q1 2021$307,000
+33.5%
43,807
-8.5%
0.00%
Q4 2020$230,000
-19.3%
47,864
-2.0%
0.00%
-100.0%
Q3 2020$285,000
+7.5%
48,861
+24.6%
0.00%0.0%
Q2 2020$265,000
+13.2%
39,200
+6.2%
0.00%0.0%
Q1 2020$234,000
-85.6%
36,900
-76.4%
0.00%
-80.0%
Q4 2019$1,627,000
+106.2%
156,036
-22.3%
0.01%
+66.7%
Q3 2019$789,000
-68.3%
200,946
+19.9%
0.01%
-71.4%
Q2 2019$2,491,000
+819.2%
167,555
+1432.6%
0.02%
+950.0%
Q1 2019$271,000
+59.4%
10,933
+88.5%
0.00%
+100.0%
Q3 2018$170,000
-93.5%
5,800
-89.8%
0.00%
-92.9%
Q2 2018$2,596,000
+5423.4%
57,100
+11140.2%
0.01%
Q3 2015$47,0005080.00%
Other shareholders
CLOVIS ONCOLOGY INC shareholders Q2 2022
NameSharesValueWeighting ↓
Palo Alto Investors LP 3,402,781$231,389,0009.96%
Versant Venture Management, LLC 101,855$6,926,140,0007.29%
Avoro Capital Advisors LLC 1,102,884$74,996,0004.86%
Redmile Group, LLC 1,320,027$89,762,0003.90%
NEXTHERA CAPITAL LP 233,200$15,858,0002.92%
Iguana Healthcare Management, LLC 60,000$4,080,0002.66%
HealthCor Management, L.P. 973,840$66,221,0002.16%
Casdin Capital, LLC 127,500$8,670,0002.11%
Prosight Management, LP 40,000$2,720,0002.00%
Camber Capital Management LP 600,000$40,800,0002.00%
View complete list of CLOVIS ONCOLOGY INC shareholders